Genovis Fair Value
GE
The fair market value of GENO.ST stock is 181.35 SEK. Relative to the market price of 22.8 SEK Genovis is undervalued by 695.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Genovis Valuation
Current GENO.ST share ticker price is 22.8 SEK.
The fair value level of 181.35 SEK can be considered as an effective entry point for long-term investors to start investing in GENO.ST stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 695% lower its fair value
Current price is 130% lower its minimum value
Current price is 1258% lower its maximum value
Market price:
GENO.ST stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
Genovis AB Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
328.86
2
Median P/E over 5 years
192.67
3
Minimum P/E over 5 years
55.6
4
Earning per share (last 12 months)
0.94 SEK
Maximum value
1
x
4
=
309.54 SEK
Fair value
2
x
4
=
181.35 SEK
Minimum value
3
x
4
=
52.33 SEK
Genovis AB price metrics
0.8
Annual return (geometric mean)
62.6
Risk (standard deviation) of returns
β
0.6
Beta (volatility compared to market)